z-logo
Premium
Molecular imaging of adrenal neoplasms
Author(s) -
Chen Clara C.,
Carrasquillo Jorge A.
Publication year - 2012
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.23162
Subject(s) - medicine , paraganglioma , pheochromocytoma , pathology , nuclear medicine
The adrenal glands are complex structures from which a variety of benign and malignant tumors may arise and are a common site of metastatic disease. Several radiopharmaceuticals are used for imaging the adrenals, including I‐123/I‐131 metaiodobenzylguanidine (MIBG), norcholesterol derivatives, In‐111 pentetreotide and Ga‐68 somatostatin analogs, [F‐18]fluorodeoxyglucose, [F‐18]fluorodopa, [F‐18]fluorodopamine, C‐11 meta hydroxyephedrine, and C‐11/F‐18/I‐123 Metomidate (MTO) or its analogs. In this review we focus on the role of these reagents in metastatic lesions, cortical neoplasms, pheochromocytoma/paraganglioma, and neuroblastoma (NB). J. Surg. Oncol. 2012; 106:532–542. © 2012 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom